{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
Source:
NUGUT by Trivia Pharmaceuticals, LLC
(2025)
Source URL:
First approved in 2025
Source:
NUGUT by Trivia Pharmaceuticals, LLC
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
Bolsitol by PureTek Corporation
(2023)
Source URL:
First approved in 2023
Source:
Bolsitol by PureTek Corporation
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT01686698: Phase 4 Interventional Completed Cirrhosis
(2013)
Source URL:
First approved in 2015
Source:
Kimchi Lactic Acid 1000 by Biogenicskorea Co., LTD
Source URL:
Class:
STRUCTURALLY DIVERSE